View in EDS HTML Full Text PDF Full Text

Effects of sacubitril/valsartan on hypertensive heart disease: the REVERSE-LVH randomized phase 2 trial.

Saved in:
Bibliographic Details
Title: Effects of sacubitril/valsartan on hypertensive heart disease: the REVERSE-LVH randomized phase 2 trial.
Authors: Lee V; National Heart Research Institute of Singapore, National Heart Centre Singapore, Singapore, Singapore., Dalakoti M; Department of Cardiology, National University Heart Centre Singapore, National University Health System, Singapore, Singapore., Zheng Q; Cochrane Singapore, Singapore, Singapore., Toh DF; National Heart Research Institute of Singapore, National Heart Centre Singapore, Singapore, Singapore., Boubertakh R; National Heart Research Institute of Singapore, National Heart Centre Singapore, Singapore, Singapore., Bryant JA; Department of Cardiology, National Heart Centre Singapore, Singapore, Singapore., Aw TC; Department of Laboratory Medicine, Changi General Hospital, Singapore, Singapore., Lee CH; Department of Cardiology, National University Heart Centre Singapore, National University Health System, Singapore, Singapore., Richards AM; Christchurch Heart Institute, University of Otago, Christchurch, New Zealand., Butler J; Baylor Scott and White Research Institute, Dallas, TX, USA.; Department of Medicine, University of Mississippi School of Medicine, Jackson, MS, USA., Díez J; Centre of Applied Medical Research (CIMA) and School of Medicine, University of Navarra, Pamplona, Spain.; Centre for Network Biomedical Research of Cardiovascular Diseases (CIBERCV), Carlos III Institute of Health, Madrid, Spain., Foo R; Department of Cardiology, National University Heart Centre Singapore, National University Health System, Singapore, Singapore.; Cardiovascular Metabolic Disease Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Cook SA; National Heart Research Institute of Singapore, National Heart Centre Singapore, Singapore, Singapore.; Department of Cardiology, National Heart Centre Singapore, Singapore, Singapore.; Cardiovascular & Metabolic Disorders SRP, Duke-NUS Medical School, Singapore, Singapore., Lam CS; National Heart Research Institute of Singapore, National Heart Centre Singapore, Singapore, Singapore.; Department of Cardiology, National Heart Centre Singapore, Singapore, Singapore.; Cardiovascular & Metabolic Disorders SRP, Duke-NUS Medical School, Singapore, Singapore., Le TT; National Heart Research Institute of Singapore, National Heart Centre Singapore, Singapore, Singapore.; Cardiovascular Medicine Academic Clinical Program (ACP), Duke-NUS Medical School, Singapore, Singapore., Chin CW; National Heart Research Institute of Singapore, National Heart Centre Singapore, Singapore, Singapore. cchin03m@gmail.com.; Department of Cardiology, National Heart Centre Singapore, Singapore, Singapore. cchin03m@gmail.com.; Cardiovascular Medicine Academic Clinical Program (ACP), Duke-NUS Medical School, Singapore, Singapore. cchin03m@gmail.com.
Source: Nature communications [Nat Commun] 2025 Jul 30; Vol. 16 (1), pp. 6981. Date of Electronic Publication: 2025 Jul 30.
Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40739095
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Effects of sacubitril/valsartan on hypertensive heart disease: the REVERSE-LVH randomized phase 2 trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Lee+V%22">Lee V</searchLink>; National Heart Research Institute of Singapore, National Heart Centre Singapore, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Dalakoti+M%22">Dalakoti M</searchLink>; Department of Cardiology, National University Heart Centre Singapore, National University Health System, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Zheng+Q%22">Zheng Q</searchLink>; Cochrane Singapore, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Toh+DF%22">Toh DF</searchLink>; National Heart Research Institute of Singapore, National Heart Centre Singapore, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Boubertakh+R%22">Boubertakh R</searchLink>; National Heart Research Institute of Singapore, National Heart Centre Singapore, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Bryant+JA%22">Bryant JA</searchLink>; Department of Cardiology, National Heart Centre Singapore, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Aw+TC%22">Aw TC</searchLink>; Department of Laboratory Medicine, Changi General Hospital, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Lee+CH%22">Lee CH</searchLink>; Department of Cardiology, National University Heart Centre Singapore, National University Health System, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Richards+AM%22">Richards AM</searchLink>; Christchurch Heart Institute, University of Otago, Christchurch, New Zealand.<br /><searchLink fieldCode="AU" term="%22Butler+J%22">Butler J</searchLink>; Baylor Scott and White Research Institute, Dallas, TX, USA.; Department of Medicine, University of Mississippi School of Medicine, Jackson, MS, USA.<br /><searchLink fieldCode="AU" term="%22Díez+J%22">Díez J</searchLink>; Centre of Applied Medical Research (CIMA) and School of Medicine, University of Navarra, Pamplona, Spain.; Centre for Network Biomedical Research of Cardiovascular Diseases (CIBERCV), Carlos III Institute of Health, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Foo+R%22">Foo R</searchLink>; Department of Cardiology, National University Heart Centre Singapore, National University Health System, Singapore, Singapore.; Cardiovascular Metabolic Disease Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Cook+SA%22">Cook SA</searchLink>; National Heart Research Institute of Singapore, National Heart Centre Singapore, Singapore, Singapore.; Department of Cardiology, National Heart Centre Singapore, Singapore, Singapore.; Cardiovascular & Metabolic Disorders SRP, Duke-NUS Medical School, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Lam+CS%22">Lam CS</searchLink>; National Heart Research Institute of Singapore, National Heart Centre Singapore, Singapore, Singapore.; Department of Cardiology, National Heart Centre Singapore, Singapore, Singapore.; Cardiovascular & Metabolic Disorders SRP, Duke-NUS Medical School, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Le+TT%22">Le TT</searchLink>; National Heart Research Institute of Singapore, National Heart Centre Singapore, Singapore, Singapore.; Cardiovascular Medicine Academic Clinical Program (ACP), Duke-NUS Medical School, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Chin+CW%22">Chin CW</searchLink>; National Heart Research Institute of Singapore, National Heart Centre Singapore, Singapore, Singapore. cchin03m@gmail.com.; Department of Cardiology, National Heart Centre Singapore, Singapore, Singapore. cchin03m@gmail.com.; Cardiovascular Medicine Academic Clinical Program (ACP), Duke-NUS Medical School, Singapore, Singapore. cchin03m@gmail.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2025 Jul 30; Vol. 16 (1), pp. 6981. <i>Date of Electronic Publication: </i>2025 Jul 30.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40739095
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41467-025-62203-0
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 6981
    Titles:
      – TitleFull: Effects of sacubitril/valsartan on hypertensive heart disease: the REVERSE-LVH randomized phase 2 trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lee V
      – PersonEntity:
          Name:
            NameFull: Dalakoti M
      – PersonEntity:
          Name:
            NameFull: Zheng Q
      – PersonEntity:
          Name:
            NameFull: Toh DF
      – PersonEntity:
          Name:
            NameFull: Boubertakh R
      – PersonEntity:
          Name:
            NameFull: Bryant JA
      – PersonEntity:
          Name:
            NameFull: Aw TC
      – PersonEntity:
          Name:
            NameFull: Lee CH
      – PersonEntity:
          Name:
            NameFull: Richards AM
      – PersonEntity:
          Name:
            NameFull: Butler J
      – PersonEntity:
          Name:
            NameFull: Díez J
      – PersonEntity:
          Name:
            NameFull: Foo R
      – PersonEntity:
          Name:
            NameFull: Cook SA
      – PersonEntity:
          Name:
            NameFull: Lam CS
      – PersonEntity:
          Name:
            NameFull: Le TT
      – PersonEntity:
          Name:
            NameFull: Chin CW
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 30
              M: 07
              Text: 2025 Jul 30
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2041-1723
          Numbering:
            – Type: volume
              Value: 16
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Nature communications
              Type: main
ResultId 1